Abbott Laboratories (ABT)

Abbott Biologicals, LLC • Abbott Cardiovascular Inc. • Abbott Cardiovascular Systems Inc. • Abbott Delaware LLC • Abbott Diabetes Care Inc. • Abbott Diabetes Care Sales Corporation • Abbott Diagnostics Scarborough, Inc. • Abbott Equity Investments LLC • Abbott Finance LLC • Abbott Global LLC ...

IRS number

360698440

ABT stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$148.50

Low target

$135.00

High target

$160.00

Latest filings (excl ownership)

View all

8-K

Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance

16 Apr 25

ARS

2024 FY

Annual report to shareholders

14 Mar 25

DEFA14A

Additional proxy soliciting materials

14 Mar 25

21 Feb 25

Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook

22 Jan 25

8-K

Departure of Directors or Certain Officers

31 Oct 24

Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range

31 Jul 24

Transcripts

View all

ABT

Earnings call transcript

2025 Q1

16 Apr 25

ABT

Earnings call transcript

2024 Q4

22 Jan 25

ABT

Earnings call transcript

2024 Q3

16 Oct 24

ABT

Earnings call transcript

2024 Q2

18 Jul 24

ABT

Earnings call transcript

2024 Q1

17 Apr 24

ABT

Earnings call transcript

2023 Q4

24 Jan 24

ABT

Earnings call transcript

2023 Q3

18 Oct 23

ABT

Earnings call transcript

2023 Q2

20 Jul 23

ABT

Earnings call transcript

2023 Q2

20 Jul 23

ABT

Earnings call transcript

2023 Q1

19 Apr 23

Latest ownership filings

View all

Patricia Paola Gonzalez

Notice of proposed sale of securities

7 Mar 25

144

Notice of proposed sale of securities

Daniel Gesua Sive Salvadori

4 Mar 25

Financial summary

Financial statements Chart ABT financial data

Quarter (USD)	Dec 24	Sep 24	Jun 24	Mar 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q4 2024

ABT institutional ownership history Ownership history

77.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2998	2862	+4.8%
Opened positions	306	190	+61.1%
Closed positions	170	164	+3.7%
Increased positions	1109	1057	+4.9%
Reduced positions	1138	1180	-3.6%

13F shares	Current	Prev Q	Change
Total value	146.47 tn	140.69 tn	+4.1%
Total shares	1.34 bn	1.28 bn	+4.9%
Total puts	7.91 mm	7.96 mm	-0.7%
Total calls	10.13 mm	8.63 mm	+17.4%
Total put/call ratio	0.8	0.9	-15.4%

Largest owners	Shares	Value	Change
Vanguard	168.65 mm	$19.08 tn	+0.4%
BlackRock	136.53 mm	$15.44 tn	+4.2%
STT State Street	77.17 mm	$8.73 tn	+0.6%
Capital International Investors	67.97 mm	$7.69 tn	+3.4%
Capital Research Global Investors	54.10 mm	$6.12 tn	+1.5%
MS Morgan Stanley	36.12 mm	$4.09 tn	+4.6%
Geode Capital Management	35.67 mm	$4.02 tn	+2.2%
JPM JPMorgan Chase & Co.	35.18 mm	$3.98 tn	+21.7%
Wellington Management	26.39 mm	$2.99 tn	+2.3%
NTRS Northern Trust	22.06 mm	$2.49 tn	+10.3%

Largest transactions	Shares	Bought/sold	Change
Norges Bank	20.98 mm	+20.98 mm	NEW
BAC Bank of America	18.78 mm	+10.66 mm	+131.3%
T. Rowe Price Investment Management	8.36 mm	+6.63 mm	+383.1%
JPM JPMorgan Chase & Co.	35.18 mm	+6.26 mm	+21.7%
RJF Raymond James Financial	5.61 mm	+5.61 mm	NEW
BlackRock	136.53 mm	+5.51 mm	+4.2%
Raymond James & Associates	0.00	-3.37 mm	EXIT
Two Sigma Advisers	1.39 mm	-2.52 mm	-64.4%
Arrowstreet Capital, Limited Partnership	230.13 k	-2.30 mm	-90.9%
Capital International Investors	67.97 mm	+2.23 mm	+3.4%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ABT insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
31 Mar 25	Alpern Robert J	Stock Equivalent Units Common Shares	Grant	Acquire A	No	No	132.65	59	7.83 k	10,093
31 Mar 25	Patricia P. Gonzalez	Stock Equivalent Units Common Shares	Grant	Acquire A	No	No	132.65	248	32.90 k	4,393
31 Mar 25	Roman Michael F	Stock Equivalent Units Common Shares	Grant	Acquire A	No	No	132.65	265	35.15 k	4,957
31 Mar 25	John G Stratton	Stock Equivalent Units Common Shares	Grant	Acquire A	No	No	132.65	277	36.74 k	11,979
7 Mar 25	Earnhardt Lisa D	Common shares without par value	Sell	Dispose S	No	No	136.645	200	27.33 k	71,928
7 Mar 25	Earnhardt Lisa D	Common shares without par value	Option exercise	Acquire M	No	No	80.98	200	16.20 k	72,128
7 Mar 25	Earnhardt Lisa D	Option Common shares	Option exercise	Dispose M	No	No	80.98	200	16.20 k	0
6 Mar 25	Earnhardt Lisa D	Common shares without par value	Sell	Dispose S	No	No	133.82	91,167	12.20 mm	71,928
6 Mar 25	Earnhardt Lisa D	Common shares without par value	Option exercise	Acquire M	No	No	80.98	91,167	7.38 mm	163,095
6 Mar 25	Earnhardt Lisa D	Option Common shares	Option exercise	Dispose M	No	No	80.98	91,167	7.38 mm	200